How to Find Companies Investing for Long-Term Innovation

How to use the screener to identify companies where substantial innovation investment shapes the balance sheet and defines where value resides.

The Question

How do I find companies that invest heavily in R&D and innovation? In knowledge-based industries, research and development spending is the primary mechanism for creating future competitive advantages. But R&D does not appear on the balance sheet — it is expensed immediately under most accounting standards, which means it reduces current earnings while creating future value that financial statements do not capture. This accounting treatment makes heavy R&D spenders look less profitable than peers who invest less, even when the investment is building a more durable competitive position.

This article examines two related structural dimensions: R&D investment intensity (how much a company spends on research relative to its business) and intangible asset concentration (how much of the balance sheet consists of non-physical assets like intellectual property, patents, brands, and acquisition goodwill). These dimensions often overlap — R&D-intensive companies tend to generate intangible assets — but they capture different aspects of how innovation investment appears in the financials. R&D spending is the current investment. Intangible assets are the accumulated result of past investments and acquisitions.

What Innovation Investment Means Structurally

Innovation investment is a structural commitment to future capability at the expense of current profitability. When a pharmaceutical company spends $4 billion annually on R&D, that spending flows through the income statement as an expense, reducing earnings and margins. But the pipeline of drug candidates it produces is an asset — one that accounting rules do not allow on the balance sheet until the products reach certain development milestones or are acquired from another company. This creates a systematic distortion in how R&D-intensive companies appear in standard financial screens: they look less profitable and less asset-rich than they actually are, because their most valuable investments are invisible to the balance sheet.

Intangible asset concentration tells a complementary story. When a company's balance sheet is dominated by intangible assets — patents, trademarks, software, customer relationships, and especially goodwill from acquisitions — the company's economic value resides in non-physical property. This is not inherently good or bad, but it is structurally distinct from companies whose value resides in factories, equipment, and inventory. Intangible-heavy companies have different risk profiles (intangible assets can lose value suddenly through technological disruption or competitive entry), different capital requirements (they often need less physical capital to grow), and different accounting characteristics (amortization schedules for intangibles may not reflect actual economic depreciation).

The screener's innovation interpretations capture these structural characteristics by measuring R&D spending intensity, tracking changes in investment levels over time, and decomposing the balance sheet into its tangible and intangible components. The combination reveals not just whether a company invests in innovation, but how central innovation investment is to the company's economic structure and where the accumulated results of that investment reside on the balance sheet.

Key Observations

R&D Intensity

What it measures: Research and development expense divided by sales, scaled so a 30% R&D-to-sales ratio reaches the maximum score. The most direct measure of innovation investment intensity relative to current revenue. The observation does not assess R&D productivity — whether the spending produces valuable output — only its structural intensity relative to the top line.

Data source: Research and development expense from the income statement divided by sales for the most recent annual period.

Intangible Assets as Share of Total Assets

What it measures: Intangible assets divided by total assets, scaled so a 0.50 ratio reaches the maximum score. Captures the snapshot share of intangibles in the asset base for the most recent balance sheet. Despite the legacy typeKey suggesting a build trajectory, the formula reads a single point-in-time ratio, not a multi-year trajectory.

Data source: Intangible assets and total assets from the most recent annual balance sheet.

CapEx to Depreciation

What it measures: Absolute capital expenditures divided by depreciation, scaled so a 3.0 ratio reaches the maximum score. A high score means current capex outpaces depreciation — the company is investing in its productive base faster than its existing assets are wearing out. The observation captures the direction and magnitude of capital reinvestment, not its efficiency or strategic value.

Data source: Capital expenditures and depreciation from the most recent annual cash flow statement and income statement.

Intangible Assets Weight

What it measures: Intangible assets divided by total non-current assets, scaled with a 20%–60% range mapped to the score band. Different denominator from 'intangible-asset-build' (non-current assets vs total assets), giving a sharper read on the share of long-term assets that is intangible rather than tangible.

Data source: Intangible assets and total non-current assets from the most recent annual balance sheet.

Goodwill to Assets (Industry-Benchmarked)

What it measures: Goodwill as a proportion of total assets, positioned within the industry peer range. Goodwill arises specifically from acquisitions — it represents the premium paid above fair value of acquired net assets. A high industry-benchmarked score means goodwill weight is in the upper portion relative to peers — reflecting heavier acquisition activity (or larger premiums paid).

Data source: Goodwill and total assets from the balance sheet, benchmarked against industry peers.

Goodwill to Equity

What it measures: Goodwill divided by total shareholders equity, scaled so a 1.5 ratio reaches the maximum score. A high score means goodwill is large relative to equity — an impairment of the goodwill balance would consume a meaningful share of book value. The typeKey 'goodwill-impairment-risk' is conventional vocabulary; the formula reads a point-in-time ratio without forecasting impairment events.

Data source: Goodwill and total shareholders equity from the most recent balance sheet.

Interpretations That Emerge

R&D Investment Profile

Constituent observations: R&D Intensity, Intangible Assets as Share of Total Assets, CapEx to Depreciation

What emerges: Three observations align. R&D expense is a meaningful share of revenue, intangible assets are a substantial share of total assets on the most recent balance sheet (a snapshot ratio, not a multi-year build trajectory), and capital expenditures exceed depreciation in the most recent annual period. Together they describe a company funding ongoing innovation (R&D), already carrying an intangible-heavy asset base, and continuing to invest in the productive base (capex outpacing depreciation). The interpretation does not measure R&D growth rate or attribute the intangible accumulation to organic vs acquired sources — those are outside what the wired observations read.

Limits: R&D spending intensity says nothing about R&D productivity. A company spending 30% of revenue on research may be producing breakthrough products with high commercial potential, or it may be burning cash on projects that never reach market. The interpretation measures the structural investment commitment without assessing whether that investment generates returns. Some of the most prolific R&D spenders in history have produced mediocre shareholder returns, while some of the most successful companies spend modestly on research but deploy it with extraordinary precision. Input does not equal output, and this interpretation measures only the input side.

Using the Screener

How do you find companies combining heavy R&D with intangible-heavy balance sheets?

Select both R&D Investment Profile and Intangible Asset Concentration to identify companies where heavy current R&D spending coincides with intangible-heavy balance sheets. This combination captures the full innovation investment picture — both the ongoing expenditure and its accumulated balance sheet footprint. Companies passing both interpretations are structurally committed to innovation as their primary value creation mechanism, with balance sheets that reflect the non-physical nature of their accumulated investments.

This screen is particularly useful for identifying potential holdings in knowledge-economy sectors where standard profitability screens systematically penalize R&D-intensive companies. A company spending heavily on research appears less profitable than peers that spend less — but the spending may be creating future revenue streams and competitive advantages that current-period profitability metrics do not capture. The innovation investment screen finds these companies before the R&D spending produces the revenue growth that conventional screens would eventually detect.

What if you want heavy R&D backed by healthy margins?

Select R&D Investment Profile combined with Margin Stack to find companies that maintain heavy R&D spending while also demonstrating healthy margins across the income statement. This combination identifies a structurally attractive configuration: the company is investing aggressively in innovation but the underlying business generates enough margin to fund that investment without financial strain. High R&D intensity with strong margins suggests either powerful pricing power (the business generates sufficient gross margin to absorb heavy research spending), or exceptional operational efficiency (the company manages non-R&D costs tightly enough to preserve profitability despite large research budgets).

The margin stack overlay filters out R&D-intensive companies that are burning cash to fund research — a pattern that may or may not produce returns — and isolates those where the current business economics support the innovation investment. This distinction matters because sustainable R&D programs are typically funded by operating cash flow from the existing business, while unsustainable ones depend on external capital that may not always be available.

Boundaries

What can innovation investment observations not tell you?

Innovation investment observations measure spending intensity and balance sheet composition. They do not measure innovation output, effectiveness, or commercial potential. A company with the highest R&D-to-revenue ratio in its industry may be producing groundbreaking products or wasting capital on projects with no market application. The relationship between R&D spending and commercial success is notoriously difficult to quantify — some of the most impactful innovations in business history emerged from modest research budgets, while some of the largest R&D programs have produced disappointing results. These observations identify the structural commitment to innovation without assessing whether that commitment is producing value.

Intangible asset observations carry additional limitations related to accounting treatment. Internally developed intangible assets — the products of a company's own R&D — are generally not recognized on the balance sheet under most accounting frameworks. This means that companies with the most valuable organically developed technology may show lower intangible-to-asset ratios than companies that acquired their technology through acquisitions (which does create balance sheet intangibles). The intangible asset concentration interpretation captures what accounting rules allow onto the balance sheet, which is a biased sample of the company's actual intangible value. Companies that grow through internal development and companies that grow through acquisition will show very different intangible profiles even if their actual intellectual property portfolios are similar in value.

Finally, R&D and intangible asset analysis is most meaningful within industry context. R&D-to-revenue ratios, intangible asset concentrations, and goodwill levels vary enormously across sectors. A 15% R&D-to-revenue ratio is unremarkable in biotechnology but extraordinary in consumer staples. A goodwill-to-assets ratio of 50% is common in companies that grow through acquisitions but absent in companies that grow organically. These observations are most informative when used to compare companies within similar industries or to track changes over time for a specific company, rather than as absolute thresholds applied across the entire market.